Dr. Michael Meneakis, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 612 N Paseo De Onate, Ste C, Espanola, NM 87532 Phone: 505-753-7355 Fax: 505-753-7533 |
Drs Mccloskey And Meneakis Optometrist Medicare: Not Enrolled in Medicare Practice Location: 612 N Paseo De Onate, Espanola, NM 87532 Phone: 505-753-7355 Fax: 505-753-7533 |
Dr. Yvonne Ann Mccloskey, OD OPTOMETRY Optometrist Medicare: Medicare Enrolled Practice Location: 612 N Paseo De Onate, Espanola, NM 87532 Phone: 505-753-7355 Fax: 505-753-7533 |
Eye Associates Of New Mexico Optometrist Medicare: Not Enrolled in Medicare Practice Location: 412 Paseo De Onate, Suite #2, Espanola, NM 87532 Phone: 505-753-7868 Fax: 505-753-6459 |
Dwight Thibodeaux Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1610 N Riverside Dr, Espanola, NM 87532 Phone: 505-747-0433 |
Optometrics Pc Optometrist - Corneal and Contact Management Medicare: Not Enrolled in Medicare Practice Location: 612 N Paseo De Onate, Espanola, NM 87532 Phone: 505-753-7355 Fax: 505-753-7533 |
News Archive
Results from a systematic review and meta analysis suggest that thyroid disease is a common comorbidity in people with vitiligo.
UT Southwestern Medical Center plastic surgeons and specialists in diabetes, neurology, pain management and rehabilitation are launching a cutting-edge study of peripheral nerve surgery to alleviate long-standing pain and numbness in patients with diabetic neuropathy.
New research from Johns Hopkins School of Medicine reveals a high value of scans which could lead to future change of reimbursement policies for follow-up positron emission tomography/computed tomography (PET/CT) studies in lung cancer. The study, featured in the February 2015 issue of the Journal of Nuclear Medicine, establishes the value of fourth and subsequent follow-up PET/CT scans in clinical assessment and management change in patients with the disease.
Mayo Clinic today announced that it has reached an agreement with Rheonix, Inc. to collaborate on the performance of a genotyping test for warfarin sensitivity in clinical and research settings.
IRIDEX Corporation today announced commercial availability of a new family of Adjustable & Intuitive EndoProbe laser handpieces for use with the Company's laser platforms in vitreoretinal surgery.
› Verified 3 days ago